Maximum Dose Reached Over 1 year of follow-up, most patients in the semaglutide 2.4 mg cohort (83.5%) reached the maximum dose of 2.4 mg, with an additional 11.2% of patients reaching a dose of 1.7 mg (Table 4)
The efficacy and safety of the new pharmacotherapies after bariatric surgery require further investigation, however the benefits of GLP-1 RA after bariatric surgery on WL and glycaemia have been shown in clinical trials [103, 104]
Chidesters team runs labs to ensure iron and vitamin levels are where they need to be
Cognitive Support: Because B12 aids in neurotransmitter synthesis, it contributes to clearer thinking, improved focus, and sharper memory
CONCLUSIONS Despite compelling evidence that patients with obesity are at higher risk for HF and that, once HF develops, patients with obesity face higher symptom burdens, lower quality of life and higher rates of HF hospitalization, little is known about the impact of intentional weight loss on HF outcomes